Collaboration will support Sanofi’s use of CytoReason’s computational disease models to develop new targets for inflammatory bowel disease (IBD).
Read more here.
- SEO Powered Content & PR Distribution. Get Amplified Today.
- Platoblockchain. Web3 Metaverse Intelligence. Knowledge Amplified. Access Here.
- Source: https://blog.ourcrowd.com/cytoreason-to-license-its-ibd-disease-model-to-sanofi-in-expanded-multiyear-multimillion-dollar-deal/
English
Arabic
Bengali
Chinese (Simplified)
Danish
Dutch
Estonian
Finnish
French
German
Greek
Hebrew
Hindi
Hungarian
Indonesian
Italian
Japanese
Korean
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Slovenian
Spanish
Swedish
Thai
Turkish
Ukrainian
Urdu
Vietnamese